Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Aug;32(8):1103-8.
doi: 10.1007/s12272-009-1801-1. Epub 2009 Aug 29.

Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases

Affiliations
Review

Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases

Claudio Napoli et al. Arch Pharm Res. .

Abstract

Nitric oxide (NO) is a pivotal signaling messenger in the cardiovascular system. NO participates in regulatory functions including control of hemostasis, fibrinolysis, platelet and leukocyte interactions with the arterial wall, regulation of vascular tone, proliferation of vascular smooth muscle cells, and homeostasis of blood pressure. Diminished NO bioavailability and abnormalities in NO-dependent signaling are among central factors of vascular disease, although it is unclear whether this is a cause of, or result of endothelial dysfunction or both pathogenic events. Disturbances in NO bioavailability have been linked to cause endothelial dysfunction, leading to increased susceptibility to atherosclerotic lesion progression, hypertension, hypercholesterolemia, diabetes mellitus, thrombosis and stroke.

Similar articles

See all similar articles

Cited by 67 articles

See all "Cited by" articles

MeSH terms

Substances

Feedback